Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EFAVIRENZ vs EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EFAVIRENZ vs EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL: Safety Overview

Metric EFAVIRENZ EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL
Total FAERS Reports 7,893 211
Deaths Reported 962 7
Death Rate 12.2% 3.3%
Hospitalizations 1,528 33
Average Patient Age 40.7 yrs 37.2 yrs
% Female Patients 37.7% 59.4%
FDA Approval Date Apr 27, 2018 N/A
Manufacturer Camber Pharmaceuticals, Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A